Arotide 50 mcg+250 mcg (Inhalation Capsule)

Indications

• Regular treatment of asthma
• Treatment with combination product
• Asthma patients not adequately controlled with inhaled corticosteroids
• Asthma patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist

Pharmacology

• Salmeterol Xinafoate is a selective, long-acting beta-2 agonist
• Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity
• Salmeterol protects against symptoms
• Fluticasone Propionate improves lung function and prevents exacerbations

Dosage

• Recommended dosage for adults and adolescents 12 years and older
• Recommended dosage for children (4-12 years)
• Dosage for adult and adolescent (12 years and older) with asthma
• Dosage for pediatric patients (4 to 11 years)
• Maxhaler dosage for adults, adolescents, and children
• Dosage for COPD patients

Administration

• Instructions for using an Inhaler
• Instructions for Cleaning Inhaler

Interaction

• Avoidance of non-selective and selective β-blockers in patients with asthma
• Potential interaction with strong CYP3A4 inhibitors

Contraindications

• Contraindicated in patients with hypersensitivity to salmeterol xinafoate or fluticasone propionate
• Contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma

Side Effects

• Adverse reactions associated with Salmeterol Xinafoate
• Adverse reactions associated with Fluticasone Propionate

Pregnancy & Lactation

• Consideration of administration during pregnancy and lactation
• Insufficient experience of use in human pregnancy and lactation

Precautions & Warnings

• Not to be initiated in patients during an exacerbation
• Avoidance for relief of acute symptoms
• Vigilance for pneumonia in COPD patients
• Potential systemic effects of inhaled corticosteroid

Use in Special Populations

• Effect on growth velocity in pediatric patients

Overdose Effects

• Signs and symptoms of Salmeterol overdose
• Signs and symptoms of Fluticasone Propionate overdose

Therapeutic Class

• Long-acting selective β-adrenoceptor stimulants
• Respiratory corticosteroids

Storage Conditions

• Pressurised canister
• Avoid puncturing, breaking, or incinerating
• Avoid storage in direct sunlight or heat
• Store below 30°C
• Keep away from eyes and children

Related Brands

• Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
• Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
• Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
• Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
• Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd